Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Fahad S Alshehri. (2023) Tapentadol: A Review of Experimental Pharmacology Studies, Clinical Trials, and Recent Findings. Drug Design, Development and Therapy 17, pages 851-861.
Read now
Read now
Flaminia Coluzzi, Francesca Felicia Caputi, Domenico Billeci, Antonio Luigi Pastore, Sanzio Candeletti, Monica Rocco & Patrizia Romualdi. (2020) Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists. Therapeutics and Clinical Risk Management 16, pages 821-837.
Read now
Read now
Richard F Howard, Tatjana Radic, Melanie Sohns, Mariëlle Eerdekens & Andrea Waßmuth. (2020) Tapentadol Prolonged Release for Long-Term Treatment of Pain in Children. Journal of Pain Research 13, pages 3157-3170.
Read now
Read now
Flaminia Coluzzi, Maria Sole Scerpa & Joseph Pergolizzi. (2020) Naldemedine: A New Option for OIBD. Journal of Pain Research 13, pages 1209-1222.
Read now
Read now
Filippo Caraci, Flaminia Coluzzi, Franco Marinangeli, Sebastiano Mercadante, Giuseppe Rinonapoli, Patrizia Romualdi, Mariaflavia Nicora & Anthony H. Dickenson. (2020) Modulation of sensitization processes in the management of pain and the importance of descending pathways: a role for tapentadol?. Current Medical Research and Opinion 36:6, pages 1015-1024.
Read now
Read now
Filippo Caraci, Flaminia Coluzzi, Franco Marinangeli, Sebastiano Mercadante, Giuseppe Rinonapoli, Patrizia Romualdi, Mariaflavia Nicora & Anthony H. Dickenson. (2020) Modulation of sensitization processes in the management of pain and the importance of descending pathways: a role for tapentadol?. Current Medical Research and Opinion 36:5, pages (I)-(XVII).
Read now
Read now
Anthony H Dickenson & Hans G Kress. (2019) Tapentadol: a new option for the treatment of cancer and noncancer pains. Journal of Pain Research 12, pages 1509-1511.
Read now
Read now
Articles from other publishers (17)
Jason W. Boland. (2023) Tapentadol for the management of cancer pain in adults: an update. Current Opinion in Supportive & Palliative Care 17:2, pages 90-97.
Crossref
Crossref
Dane KrtinićA.A., Ljiljana GvozdenovićV.V., Sanja VickovićV.V., Aleksandra Lučić-ProkinL.L., Aleksandar KneževićL.L., Dragana MilijaševićS.S., Gorana Nedin-RankovićG.G., Biljana ŽivadinovićS.S., Ranko ZdravkovićM.M., Mirjana Todorović-MitićM.M., Aleksandar StojanovD.D., Hristina JovanovićM.M., Hristina TrajkovićS.S., Mladen ĐorđevićS.S., Marija JevtićR.R. & Irena ConićG.G.. (2023) Pharmacotherapy of cancer pain with opioid analgesics. Hospital Pharmacology - International Multidisciplinary Journal 10:1, pages 1264-1275.
Crossref
Crossref
Flaminia Coluzzi, Maria Sole Scerpa, Monica Rocco & Diego Fornasari. (2022) The Impact of P-Glycoprotein on Opioid Analgesics: What’s the Real Meaning in Pain Management and Palliative Care?. International Journal of Molecular Sciences 23:22, pages 14125.
Crossref
Crossref
Iris Appelmann & Roman Rolke. (2022) Aktuelle Schmerztherapie bei Tumorpatienten. Im Fokus Onkologie 25:3, pages 15-20.
Crossref
Crossref
Preeti Manandhar, Mark Connor & Marina Santiago. (2022) Tapentadol shows lower intrinsic efficacy at µ receptor than morphine and oxycodone. Pharmacology Research & Perspectives 10:1.
Crossref
Crossref
R.R. Sarmanaeva, G.R. Abuzarova, E.V. Gameeva, Yu.V. Brazhnikova & S.V. Kuznetsov. (2022) Clinical example of long-term opioid therapy with tapentadol for chronic pain in oncology. Onkologiya. Zhurnal imeni P.A.Gertsena 11:1, pages 55.
Crossref
Crossref
L. Brullot, G. Hans, P.J. Germonpré, D. Mesotten, T. Vanneste & K. Van Boxem. (2021) Retrospectieve praktijkanalyse van tapentadol met vertraagde afgifte bij patiënten met chronische pijn refractair aan sterke opioïden. Tijdschrift voor Geneeskunde.
Crossref
Crossref
Alfonso ORIENTE, Elsa MAZZARELLA & Antonio DEL PUENTE. (2021) Effectiveness and tolerability of tapentadol PR in the management of vertebral fracture pain due to bone fragility. Minerva Ortopedica e Traumatologica 71:4.
Crossref
Crossref
Flaminia Coluzzi, Monica Rocco, Rula Green Gladden, Pietro Persiani, Laurel A. Thur & Filippo Milano. (2020) Pain Management in Childhood Leukemia: Diagnosis and Available Analgesic Treatments. Cancers 12:12, pages 3671.
Crossref
Crossref
Flaminia Coluzzi & Sebastiano Mercadante. (2020) The Potential Role of Dual Mechanistic Opioids in Combating Opioid Misuse. Current Anesthesiology Reports 10:4, pages 416-422.
Crossref
Crossref
Shoichiro Sazuka & Toshiya Koitabashi. (2020) Tapentadol is effective in the management of moderate-to-severe cancer-related pain in opioid-naïve and opioid-tolerant patients: a retrospective study. Journal of Anesthesia 34:6, pages 834-840.
Crossref
Crossref
Mateusz Wojciech Kucharczyk, Diane Derrien, Anthony Henry Dickenson & Kirsty Bannister. (2020) The Stage-Specific Plasticity of Descending Modulatory Controls in a Rodent Model of Cancer-Induced Bone Pain. Cancers 12:11, pages 3286.
Crossref
Crossref
L. Flöther. (2020) Schmerztherapie bei HNO-PalliativpatientenPain therapy in palliative ENT patients. HNO 68:7, pages 503-509.
Crossref
Crossref
Xiao-Fang Mao, Muhammad Zaeem Ahsan, Evhy Apryani, Xue-Qi Tang, Meng-Jing Zhao, Xin-Yan Li & Yong-Xiang Wang. (2020) Dual μ-opioid receptor and norepinephrine reuptake mechanisms contribute to dezocine- and tapentadol-induced mechanical antiallodynia in cancer pain. European Journal of Pharmacology 876, pages 173062.
Crossref
Crossref
Lukas Radbruch, Martin Mücke, Helmut Hoffmann-Menzel & Henning Cuhls. 2020. The Senses: A Comprehensive Reference. The Senses: A Comprehensive Reference
636
655
.
Flaminia Coluzzi, Roman Rolke & Sebastiano Mercadante. (2019) Pain Management in Patients with Multiple Myeloma: An Update. Cancers 11:12, pages 2037.
Crossref
Crossref
Praveen Anand, Anthony Dickenson, Gabriele Finco, Franco Marinangeli, Enrico Polati, Patrizia Romualdi, Thomas M Tzschentke & Pier Luigi Canonico. (2019) Novel insights on the management of pain: highlights from the ‘Science of Relief’ meeting. Pain Management 9:6, pages 521-533.
Crossref
Crossref